Search for a clinical trial
Other search option(s)
14 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
rhLaman-08: A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis - AT
Institution: Information not provided - AT
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
rhLaman-08: 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis (Phase II) - FR
Institution: Information not provided - FR
GERMANY
Rheinland-Pfalz
MAINZ
rhLaman-08: A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis - DE
Universitätsmedizin Mainz
Zentrum für Kinder- und Jugendmedizin
ITALY
EMILIA ROMAGNA
PARMA
ITALY
EMILIA ROMAGNA
PARMA
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
A Multi-Center, Open-Label Trial of the Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis - BE
Universitair Ziekenhuis Brussel - UZ Brussel
KidZ Health Castle (kinderziekenhuis van het UZ Brussel)
DENMARK
Hovedstaden
COPENHAGEN
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating the Efficacy and Safety of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis (Phase III) - FR
Rigshospitalet
Department of Clinical Genetics and Paediatrics
DENMARK
Hovedstaden
COPENHAGEN
rhLAMAN-10: A Single Center, Open Label Clinical Trial Investigating the Long-term Efficacy of rhLAMAN (Recombinant Human Alpha-mannosidase or Lamazym) Treatment in Subjects With Alpha-Mannosidosis Who Previously Participated in Lamazym Trials (Phase III)
Rigshospitalet
Department of Clinical Genetics and Paediatrics
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
A multi-center, un-controlled, open-labeled trial of the long-term safety of Lamazym aftercare treatment of subjects with alpha-Mannosidosis who previously participated in Lamazym-trials (Phase III) - FR
Institution: Information not provided - FR
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
A Multi-Center, Open-Label Trial of the Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis (Phase II) - ES (Completed)
Institution: Information not provided - ES
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial, Investigating the Efficacy and Safety of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis (Phase III) - ES (completed)
Institution: Information not provided - ES
UNITED KINGDOM
Greater Manchester
MANCHESTER
rhLAMAN-04 - A Multi-Center, Open-Label Trial of the Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis (Phase II) - UK
St Mary's Hospital
Manchester Cente for Genomic Medicine
Multinational clinical trial(s)
ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
A 24-month Multicenter, Open-label Phase II Trial Investigating the Safety and Efficacy of Repeated Velmanase Alfa (Recombinant Human Alpha-mannosidase) Treatment in Pediatric Patients Below 6 Years of Age With Alpha-Mannosidosis
Institution: Information not provided - IT
DENMARK
Hovedstaden
COPENHAGEN